Undue Fear of Inducements in Research in Developing Countries
Prematurely born children who have underdeveloped lungs may suffer a potentially fatal condition called respiratory distress syndrome. A U.S. company developed a drug, called Surfaxin, to treat such poorly functioning lungs. A placebo-controlled study was planned in four Latin American countries (Me...
Authors: | ; |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Cambridge Univ. Press
2009
|
In: |
Cambridge quarterly of healthcare ethics
Year: 2009, Volume: 18, Issue: 2, Pages: 122-129 |
Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |